Creating, facilitating, and promoting sustainable Health Technology Assessment (HTA) cooperation in Europe
-
PTJA04 – “Sotagliflozin indicated as an adjunct to insulin therapy to improve glycaemic control in adults with type 1 diabetes mellitus with a Body Mass Index (BMI) ≥ 27 kg/m2, who have failed to achieve adequate glycaemic control despite optimal insulin therapy” is now available
This is the assessment of the relative effectiveness of ‘Sotagliflozin indicated as
-
Open Call for Patient Group Input – Collaborative Assessment on a Medical Device for Rectum Spaces for Prostate Cancer Radiotherapy
EUnetHTA recently started a new Collaborative Assessment on a Medical Device for
